2023
Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report
Miller C, Taylor-Salmon E, Emuren L, Landry M, Gershon A, Miller G. Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report. BMC Infectious Diseases 2023, 23: 854. PMID: 38057696, PMCID: PMC10698951, DOI: 10.1186/s12879-023-08809-5.Peer-Reviewed Original ResearchConceptsVaricella-zoster virusVZV reactivationVaccine-strain varicella-zoster virusSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Latent varicella zoster virusSymptomatic COVID-19 infectionRespiratory syndrome coronavirus 2SARS-CoV2 infectionSyndrome coronavirus 2COVID-19 infectionVaccine-type strainsSARS-CoV-2Vesicular rashPediatric patientsSignificant morbidityClinical syndromeCoronavirus 2Single doseCase reportGeneral populationMechanical traumaDisease processHZ casesPhysiologic stress
1998
Papular-Purpuric Gloves and Socks Syndrome Associated with Acute Parvovirus B19 Infection: Case Report and Review
Smith P, Landry M, Carey H, Krasnoff J, Cooney E. Papular-Purpuric Gloves and Socks Syndrome Associated with Acute Parvovirus B19 Infection: Case Report and Review. Clinical Infectious Diseases 1998, 27: 164-168. PMID: 9675471, DOI: 10.1086/514629.Peer-Reviewed Original ResearchConceptsAcute parvovirus B19 infectionPapular-purpuric glovesParvovirus B19 infectionParvovirus B19B19 infectionCases of PPGSSTypical clinical syndromeSerial serologyAcute phaseOral erosionsSocks syndromeConvalescent periodIgM antibodiesSyndrome AssociatedClinical syndromeCase reportUnusual syndromeSyndromeDermatology literatureInfectionCausative agentPPGSSB19AntibodiesMost cases